Journal of Immunotherapy and Precision Oncology
The Journal of Immunotherapy and Precision Oncology (JIPO) is a peer-reviewed open-access journal published quarterly since 2018. JIPO aims to publish high-quality articles that appeal to a broad readership of healthcare professionals and scientists, especially those with an interest in immunotherapy and precision oncology. Topics in the Journal include studies of immune system function and biology, new therapeutic approaches to different malignancies, mechanisms of resistance, clinical assessment, prognostic or predictive markers, targeted therapy, and more. Please visit jipoonline.org to learn more and submit a manuscript.
Pharma Phorum media is the premier digital publisher of thought leadership relating to the pharmaceutical industry. The news, opinions and insights published every day help industry executives better understand the broader healthcare landscape within which they operate, including regular contributions from their peers, innovative service providers, physicians, payers / policy makers, patient organisations and patients. Core channels include pharmaphorum.com, our new digital journal Deep Dive and a highly engaged social media audience through multiple platforms.